Table 2.
COVID-19 symptoms and outcomes of included patients with SARS-CoV-2 infection during pregnancy. Data presented as median and IQR or numbers (%).
| COVID-19 during Pregnancy | |
|---|---|
| Symptoms | |
| Headache, n/n Total (%) | 11/17 (64.7%) |
| Chills, n/n Total (%) | 6/17 (35.3%) |
| Fever, n/n Total (%) | 7/17 (41.2%) |
| Duration of fever, days (IQR) | 3.0 (1.0–19.0) |
| Sneeze, n/n Total (%) | 7/17 (41.2%) |
| Rhinitis, n/n Total (%) | 12/17 (70.6%) |
| Loss of smell/taste, n/n Total (%) | 13/17 (76.5%) |
| Sore throat, n/n Total (%) | 9/17 (52.9%) |
| Cough, n/n Total (%) | 12/17 (70.6%) |
| Dyspnea, n/n Total (%) | 8/17 (47.1%) |
| Conjunctivitis, n/n Total (%) | 1/16 (6.3%) |
| Arthralgia, n/n Total (%) | 6/17 (35.3%) |
| Myalgia, n/n Total (%) | 8/17 (47.1%) |
| Vertigo/fatigue, n/n Total (%) | 11/17 (64.7%) |
| Nausea, n/n Total (%) | 8/17 (47.1%) |
| Emesis, n/n Total (%) | 5/17 (29.4%) |
| Diarrhea, n/n Total (%) | 4/17 (23.5%) |
| Outcomes | |
| Hospital admission, n/n Total (%) | 2/23 (8.7%) |
| Intensive care unit admission, n/n Total (%) | 0/23 (0.0%) |
| Non-invasive ventilation, n/n Total (%) | 0/23 (0.0%) |
| Intubation, n/n Total (%) | 0/23 (0.0%) |